
51 - 200 employees
Founded 2020
💼 Consulting
🏥 Healthcare
📦 Logistics
💰 Pre Seed Round on 2022-03
Consulting • Healthcare • Logistics
Lifelancer is an AI-powered talent hiring platform that connects employers with skilled professionals in the Life Sciences, Pharmaceutical, and IT sectors. It enables individuals to create profiles showcasing their skills, get matched with high-paying international jobs or projects, and facilitates hiring and payroll for employers in multiple countries. The platform aims to streamline the hiring process with efficient AI sourcing and compliance support.
🕒 Yesterday
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2020
💼 Consulting
🏥 Healthcare
📦 Logistics
💰 Pre Seed Round on 2022-03
Consulting • Healthcare • Logistics
Lifelancer is an AI-powered talent hiring platform that connects employers with skilled professionals in the Life Sciences, Pharmaceutical, and IT sectors. It enables individuals to create profiles showcasing their skills, get matched with high-paying international jobs or projects, and facilitates hiring and payroll for employers in multiple countries. The platform aims to streamline the hiring process with efficient AI sourcing and compliance support.
• Serve as clinical scientist lead on one or more early-stage Phase 1/2 clinical trials for Orexin-targeted programs in neurodegeneration and/or neuropsychiatric indications • Contribute to clinical development plan strategy, including study design, dose-escalation/titration strategy, and data interpretation • Lead development, authorship, and review of clinical and cross-functional documents, including protocols, amendments, investigator brochures, eCRFs, completion guidelines, SAP/TLF shells, and regulatory briefing materials • Serve as study medical/scientific lead from study start-up through clinical study report completion • Lead CRF design, enrollment monitoring, and patient profile review • Drive dose-escalation and study conduct discussions through real-time review and interpretation of emerging safety, PK/PD, and biomarker data • Provide scientific leadership and recommendations in data review meetings, safety review committees, governance forums, and cross-functional team discussions • Partner with Clinical Operations, Translational Science, Regulatory Affairs, Biostatistics, and Safety/Pharmacovigilance • Drive cross-functional alignment and execution for high-quality, timely study delivery • Collaborate with Translational and Preclinical teams to integrate biomarker and mechanistic hypotheses into clinical studies and development strategy • Identify and address scientific, operational, and strategic risks and gaps • Review and interpret clinical safety, efficacy, PK/PD, and exploratory biomarker data • Develop scientific insights and recommendations for clinical development strategy and decision-making • Contribute to regulatory submissions, health authority responses, governance materials, and external scientific communications • Support abstracts, posters, manuscripts, and presentations for scientific meetings and publications • Provide scientific leadership in interactions with investigators, CROs, vendors, and external experts • Lead or support investigator meetings and scientific training sessions • Represent clinical science in interactions with key opinion leaders and scientific advisory boards • Manage deliverables across assigned studies and workstreams • Mentor and support junior clinical scientists, depending on scope
• Advanced scientific/clinical degree; PhD or PharmD strongly preferred • 8–10 years of experience in clinical research or clinical development within the biotechnology or pharmaceutical industry • Strong scientific foundation in neuroscience/neurology required • Experience in neurodegeneration and/or neuropsychiatric indications strongly preferred • Familiarity with Orexin biology or related sleep/wake and neurocircuitry mechanisms is a plus • Deep understanding of clinical trial design, clinical data analysis, and drug development principles • Direct experience leading or supporting early-phase (Phase 1/2) clinical trials • Demonstrated ability to independently lead complex scientific workstreams and influence cross-functional teams in a fast-paced biotech environment • Proven experience leading development and authorship of clinical and regulatory documents, including protocols, IBs, CSRs, and briefing documents • Strong analytical and scientific interpretation skills • Ability to synthesize emerging clinical, safety, and biomarker data into actionable insights • Excellent written and verbal communication skills • Ability to clearly communicate complex scientific concepts to diverse audiences • Role based in the United States • Ability to travel occasionally
• Company bonus, depending in part on company and individual performance • Company-sponsored 401(k) • Pension • Vacation benefits • Medical, dental, vision, and prescription drug benefits • Flexible benefits, including healthcare and/or dependent day care flexible spending accounts • Life insurance and death benefits • Time off and leave of absence benefits • Well-being benefits, including employee assistance program, fitness benefits, and employee clubs and activities • Remote work arrangement • Occasional travel
Apply Now🕒 3 days ago
Senior Advisor leading delivery of Massachusetts’s statewide vaccine management and clinical case management system. Translating local health department needs into product requirements, workflows, and adoption strategies.
🕒 October 10
Clinical science advisor leading Phase 2–3 Orexin trials at Lilly/Centessa. Driving study execution, data interpretation, and clinical development for sleep-wake medicines.
🇺🇸 United States – Remote
💵 $153k - $268.4k / year
💰 $6.5M Post-IPO Debt - Eli Lilly on 2024-02
⏰ Full Time
🟠 Senior
🕒 October 10
Senior clinical scientist leading Phase 1/2 Orexin trials for Centessa Pharmaceuticals, developing medicines for narcolepsy and neurological disorders. Driving study strategy, clinical data interpretation, and regulatory documents.
🇺🇸 United States – Remote
💵 $168k - $283.8k / year
💰 $6.5M Post-IPO Debt - Eli Lilly on 2024-02
⏰ Full Time
🟠 Senior
🕒 October 9
Clinical science leader advancing Centessa’s Orexin medicines through Phase 1/2 trials. Guiding study design, data interpretation, regulatory documents, and cross-functional development strategy.
🇺🇸 United States – Remote
💵 $168k - $283.8k / year
💰 $6.5M Post-IPO Debt - Eli Lilly on 2024-02
⏰ Full Time
🟠 Senior
🕒 October 9
Clinical scientist leading Phase 2-3 Orexin trials for Centessa, Lilly’s sleep-medicine subsidiary. Driving study strategy, execution, data review, and regulatory documentation.
🇺🇸 United States – Remote
💵 $153k - $268.4k / year
💰 $6.5M Post-IPO Debt - Eli Lilly on 2024-02
⏰ Full Time
🟠 Senior